Abstract:Background: The chromodomain helicase DNA-binding protein 2 (CHD2) gene, is an ATPase and part of the CHD family of chromatin remodelers. Mutations in the CHD2 gene are inherited in an autosomal-dominant manner and can lead to intellectual disability, epilepsy, and autism. We investigated the clinical characteristics of CHD2-related conditions and their possible pathogenesis.Methods: We collected and analysed the clinical data of patients that were identified as having CHD2 mutations. Genetic testing was performed using targeted sequencing or whole-exome sequencing. We analysed the expression of CHD2 and repressor element 1-silencing transcription factor (REST) in blood samples using quantitative PCR and the conservation of the mutations. The CHD2 mutations we identified were compared with the known mutations reported in the CHD2-related literature.Results: Eight patients with CHD2 gene mutations were analysed. Six mutations were identified; four were unreported previously (c.670C>T; c.4012A>C; c.2416dup; c.1727-1728insAT), and two were known mutations: c.5035C>T (two cases) and c.4173dup (two cases). Among these mutations, seven were de novo mutations, and one could not be determined because the parents refused genetic testing. The clinical manifestations included mild or severe intellectual disability, epilepsy, and behavioural abnormalities. Quantitative PCR showed that the CHD2 gene expression levels among the patients, parents, and the controls were not significantly different. The levels of REST gene expression in the patients were significantly higher than those of the controls; thus, mutation of the CHD2 gene led to an increase in the expression level of the REST gene. The mutations reported were all located in conserved positions in different species. Among the various medications administered for treatment, valproate showed the best results for the treatment of epilepsy caused by CHD2 gene mutation.Conclusion: Mutation in CHD2 did not lead to a significant decrease in its expression level, indicating that the clinical phenotype was unrelated to its expression level, and the mutant protein may retain some function. Most of the mutations relatively stable. In addition, the clinical manifestations from the same mutation in the CHD2 gene were different among the known cases; this may be related to the regulation of REST or other regulatory factors.

Related Genes and Proteins of Chediak-Higashi Syndrome

Whole Genome Sequencing Identifies Novel Compound Heterozygous Lysosomal Trafficking Regulator Gene Mutations Associated with Autosomal Recessive Chediak-Higashi Syndrome

Identification of a Novel CHS1/ LYST Variant in a Chinese Pedigree Affected with Chediak-Higashi Syndrome

Accelerated Phase Development in a Late-Onset Adolescent Chediak-Higashi Syndrome Patient Caused by Compound Novel LYST Mutations in the Setting of SARS-CoV-2 Infection

Bone Marrow Transplantation from an HLA-matched Unrelated Donor for Treatment of Chediak-Higashi Syndrome.

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Identification of proteins in the ceroid-like autofluorescent aggregates from liver lysosomes of Beige, a mouse model for human Chediak-Higashi syndrome.

Lysosomal Membranes from Beige Mice Contain Higher Than Normal Levels of Endoplasmic Reticulum Proteins.

Chediak Higashi Syndrome with Hemophagocytic Lymphohistiocytosis

A girl with a novel nonsense mutation in Chediak-Higashi syndrome was relieved successfully by treatment with HCST and UCBT: a case report

The Single Nucleotide Polymorphisms in Smad-interacting Protein 1 Gene Contribute to Its Ectopic Expression and Susceptibility in Hirschsprung's Disease.

Heterozygous Deletion of the SHOX Gene Enhancer in Two Females with Clinical Heterogeneity Associating with Skewed XCI and Escaping XCI

Comparative Proteomics of Hirschsprung's Disease

Molecular characterization of the protein encoded by the Hermansky-Pudlak syndrome type 1 gene

Rare X-Linked Hypohidrotic Ectodermal Dysplasia in Females Associated with <i>Ectodysplasin-A</i> Variants and the X-Chromosome Inactivation Pattern

Functional Analysis of Two SLC9A6 Frameshift Variants in Lymphoblastoid Cells from Patients with Christianson Syndrome.

Clinical, Biochemical, and Genetic Analysis of 28 Chinese Patients with Holocarboxylase Synthetase Deficiency.

Biallelic variants in SLC26A2 cause multiple epiphyseal dysplasia-4 by disturbing chondrocyte homeostasis

Clinical Study of 8 Cases of <i>CHD2</i> Gene Mutation-Related Neurological Diseases and Their Mechanisms

Novel Mutations in Chinese Hypotrichosis Simplex Patients Associated with LSS Gene.

Characterization of Biologic Behaviors and Cdna Expression of Articular Chondrocytes in Spondyloepiphyseal Dysplasia Tarda with Progressive Arthropathy